Theodore S. Steiner

9.1k total citations · 5 hit papers
97 papers, 5.9k citations indexed

About

Theodore S. Steiner is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Theodore S. Steiner has authored 97 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 32 papers in Immunology and 22 papers in Epidemiology. Recurrent topics in Theodore S. Steiner's work include Clostridium difficile and Clostridium perfringens research (23 papers), Immune Cell Function and Interaction (18 papers) and Immune Response and Inflammation (18 papers). Theodore S. Steiner is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (23 papers), Immune Cell Function and Interaction (18 papers) and Immune Response and Inflammation (18 papers). Theodore S. Steiner collaborates with scholars based in Canada, United States and Brazil. Theodore S. Steiner's co-authors include Megan K. Levings, Richard L. Guerrant, Natasha K. Crellin, James P. Nataro, Megan E. Himmel, Sarah Q. Crome, Phillip I. Tarr, Larry K. Pickering, Maria Grazia Roncarolo and Laura Passerini and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.

In The Last Decade

Theodore S. Steiner

95 papers receiving 5.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

2007 713 citations Sarah Q. Crome, Natasha K. Crellin et al. International Immunology profile →
Practice Guidelines for the Management of Infectious Diarrhea

2001 685 citations Richard L. Guerrant, Theodore S. Steiner et al. Clinical Infectious Diseases profile →
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection

2016 477 citations Theodore S. Steiner et al. profile →
2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea

2017 345 citations Theodore S. Steiner et al. Clinical Infectious Diseases profile →
2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea

2017 311 citations Theodore S. Steiner et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Theodore S. Steiner

Since Specialization

Citations

This map shows the geographic impact of Theodore S. Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore S. Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore S. Steiner more than expected).

Fields of papers citing papers by Theodore S. Steiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodore S. Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore S. Steiner. The network helps show where Theodore S. Steiner may publish in the future.

Co-authorship network of co-authors of Theodore S. Steiner

This figure shows the co-authorship network connecting the top 25 collaborators of Theodore S. Steiner. A scholar is included among the top collaborators of Theodore S. Steiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodore S. Steiner. Theodore S. Steiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB.1.5 spike protein 2024 ·Nature Communications ·Dhiraj Mannar, James W. Saville, (unknown), Xing Zhu, (unknown), (unknown), (unknown), Katherine R. Tuttle, (unknown), (unknown), Laura Cook, Theodore S. Steiner, Sriram Subramaniam	8
2	PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection 2024 ·Clinical Infectious Diseases ·Paul Feuerstadt, Teena Chopra, W Knapple, (unknown), Erik R. Dubberke, (unknown), (unknown), (unknown), Michael Gamborg, Theodore S. Steiner, Daniel Van Handel, Sahil Khanna	17
3	40 EFFECTS OF LYOPHILIZED FECAL FILTRATE COMPARED TO LYOPHILIZED DONOR STOOL IN THE TREATMENT OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A MULTI-CENTER, DOUBLEBLINDED RANDOMIZED TRIAL 2024 ·Gastroenterology ·Dina Kao, Karen Wong, Christine Lee, Theodore S. Steiner, (unknown), (unknown), Marisela Silva, Jens Walter, Huiping Xu, Raimar Löebenberg, Maryna Yaskina, Karen V. MacDonald, Deborah A. Marshall, Thomas Louie	1
4	T‐cell activation–induced marker assays in health and disease 2023 ·Immunology and Cell Biology ·(unknown), (unknown), Sabine Ivison, Megan K. Levings, Theodore S. Steiner, Laura Cook	45
5	Clostridioides difficile PCR Tcdb Cycle Threshold predicts toxin EIA positivity but not severity of infection 2023 ·Anaerobe ·(unknown), (unknown), Theodore S. Steiner, Aleksandra Stefanovic	3
6	Improving care for patients with Clostridioides difficile infection: A clinical practice and healthcare systems perspective 2023 ·Frontiers in Medicine ·(unknown), Mark H. Wilcox, Nicola Petrosillo, Paul M. Griffin, Theodore S. Steiner, (unknown), Joël Doré, (unknown), Stephanie Stockwell, Robert J. Romanelli, Sonja Marjanovic	1
7	Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication 2022 ·Molecular Biomedicine ·Tirosh Shapira, Selvarani Vimalanathan, (unknown), (unknown), (unknown), (unknown), William D. Rees, Dirk Winkler, (unknown), Theodore S. Steiner, François Jean, Steven Pelech, Yossef Av‐Gay	8
8	Flagellin-specific human CAR Tregs for immune regulation in IBD 2022 ·Journal of Autoimmunity ·Dominic A. Boardman, May Q. Wong, William D. Rees, Dan Wu, Megan E. Himmel, Paul C. Orban, Jens Vent‐Schmidt, Nicholas C. Zachos, Theodore S. Steiner, Megan K. Levings	29
9	Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B 2020 ·Gastroenterology ·Laura Cook, William D. Rees, May Q. Wong, William W. Kwok, Megan K. Levings, Theodore S. Steiner	9
10	Metagenomic Investigation of Plasma in Individuals with ME/CFS Highlights the Importance of Technical Controls to Elucidate Contamination and Batch Effects 2016 ·PLoS ONE ·Ruth R. Miller, Miguel Uyaguari, (unknown), Vincent Montoya, Jennifer L. Gardy, (unknown), Theodore S. Steiner, William Hsiao, (unknown), Patrick Tang, David M. Patrick, (unknown)	14
11	Environmental influences on T regulatory cells in inflammatory bowel disease 2011 ·Seminars in Immunology ·Gijs Hardenberg, Theodore S. Steiner, Megan K. Levings	34
12	Autoactivation of the AggR regulator of enteroaggregativeEscherichia coli in vitroandin vivo 2010 ·FEMS Immunology & Medical Microbiology ·Nicholas Morin, (unknown), Sabine Ivison, Ajinder Kaur, James P. Nataro, Theodore S. Steiner	6
13	Protein kinase D1 and D2 are involved in chemokine release induced by toll-like receptors 2, 4, and 5 2010 ·Cellular Immunology ·Theodore S. Steiner, Sabine Ivison, Yu Yao, (unknown)	17
14	The Stress signal extracellular ATP modulates antiflagellin immune responses in intestinal epithelial cells 2010 ·Inflammatory Bowel Diseases ·Sabine Ivison, Megan E. Himmel, (unknown), Yu Yao, (unknown), Megan K. Levings, Theodore S. Steiner	20
15	Dexamethasone in Cryptococcus gattii Central Nervous System Infection 2009 ·Clinical Infectious Diseases ·Peter Phillips, Kristine Chapman, Madeleine Sharp, (unknown), (unknown), Theodore S. Steiner, William Bowie	37
16	Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production breakdown → 2007 ·International Immunology ·(unknown), Sarah Q. Crome, Natasha K. Crellin, Laura Passerini, Theodore S. Steiner, Rosa Bacchetta, Maria Grazia Roncarolo, Megan K. Levings	713
17	Méningite bactérienne chez le patient VIH positif : pensez aux co-infections ! 2006 ·Annales Françaises d Anesthésie et de Réanimation ·J. Nadaud, (unknown), (unknown), (unknown), (unknown), Theodore S. Steiner, (unknown), M Rüttimann, (unknown)	1
18	Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells 2005 ·The Journal of Immunology ·Natasha K. Crellin, Rosa V. Garcia, (unknown), Sarah Allan, Theodore S. Steiner, Megan K. Levings	300
19	Role of Inducible Cyclooxygenase and Prostaglandins inClostridium difficileToxin A–Induced Secretion and Inflammation in an Animal Model 2001 ·The Journal of Infectious Diseases ·Cirle Alcantara, William F. Stenson, Theodore S. Steiner, Richard L. Guerrant	37
20	Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells 2000 ·Journal of Clinical Investigation ·Theodore S. Steiner, James P. Nataro, Celeste E. Poteet-Smith, Jeffrey A. Smith, Richard L. Guerrant	199

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact